| Solano Center Of Excellence Medical Corp | |
|
1760 Tuolumne St Vallejo CA 94589-2619 | |
| (707) 551-3360 | |
| (707) 643-3018 |
| Full Name | Solano Center Of Excellence Medical Corp |
|---|---|
| Speciality | Clinic/Center |
| Location | 1760 Tuolumne St, Vallejo, California |
| Authorized Official Name and Position | Kaynita Atalig (PRACTICE MANAGER) |
| Authorized Official Contact | 7075513319 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Solano Center Of Excellence Medical Corp 100 Hospital Dr Ste 110 Vallejo CA 94589-2577 Ph: (707) 551-3300 | Solano Center Of Excellence Medical Corp 1760 Tuolumne St Vallejo CA 94589-2619 Ph: (707) 551-3360 |
| NPI Number | 1194103796 |
|---|---|
| Provider Enumeration Date | 05/14/2015 |
| Last Update Date | 08/04/2021 |
| Medicare PECOS PAC ID | 2961718648 |
|---|---|
| Medicare Enrollment ID | O20150825005353 |
News Archive
Researchers from the University of Exeter Medical School have for the first time identified the mechanism that protects us from developing uncontrollable fear.
Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.
In Switzerland, as in most industrialized countries, nearly 1% of children are born "very prematurely", i.e. before the 32nd week of pregnancy, which represents about 800 children yearly.
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune.
Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194103796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Raquel C Cripe |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1912922782 PECOS PAC ID: 9931185683 Enrollment ID: I20040624001649 |
News Archive
Researchers from the University of Exeter Medical School have for the first time identified the mechanism that protects us from developing uncontrollable fear.
Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.
In Switzerland, as in most industrialized countries, nearly 1% of children are born "very prematurely", i.e. before the 32nd week of pregnancy, which represents about 800 children yearly.
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune.
Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed.
› Verified 7 days ago
| Provider Name | Nantida Hong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932300621 PECOS PAC ID: 8325128093 Enrollment ID: I20120125000888 |
News Archive
Researchers from the University of Exeter Medical School have for the first time identified the mechanism that protects us from developing uncontrollable fear.
Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.
In Switzerland, as in most industrialized countries, nearly 1% of children are born "very prematurely", i.e. before the 32nd week of pregnancy, which represents about 800 children yearly.
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune.
Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed.
› Verified 7 days ago
| Provider Name | Saw Sein |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053754473 PECOS PAC ID: 0547537136 Enrollment ID: I20170602000966 |
News Archive
Researchers from the University of Exeter Medical School have for the first time identified the mechanism that protects us from developing uncontrollable fear.
Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.
In Switzerland, as in most industrialized countries, nearly 1% of children are born "very prematurely", i.e. before the 32nd week of pregnancy, which represents about 800 children yearly.
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune.
Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed.
› Verified 7 days ago
News Archive
Researchers from the University of Exeter Medical School have for the first time identified the mechanism that protects us from developing uncontrollable fear.
Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.
In Switzerland, as in most industrialized countries, nearly 1% of children are born "very prematurely", i.e. before the 32nd week of pregnancy, which represents about 800 children yearly.
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2009 of approximately $71 million, as compared with $69 million for the third quarter of 2008. Royalty revenues are based on second quarter product sales by PDL's licensees and include $1.6 million for Synagis(R), which is marketed by MedImmune.
Over the past several decades, neurostimulation techniques such as transcranial direct current stimulation (tDCS) have gradually gained favour in the public eye. In a new report, published yesterday in the prestigious scientific journal Neuron, IRCM ethics experts raise important questions about the rising tide of tDCS coverage in the media, while regulatory action is lacking and ethical issues need to be addressed.
› Verified 7 days ago
California Maritime Academy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Maritime Academy Dr, Vallejo, CA 94590 Phone: 707-654-1170 Fax: 707-654-1171 | |
Solano Primary Care Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 155 Glen Cove Marina Rd E # 10, Vallejo, CA 94591 Phone: 707-558-8699 | |
Voltaire S. Velarde Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 646 Tennessee St, Vallejo, CA 94590 Phone: 707-552-7111 | |
Jaime M. Singzon, M.d., Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 646 Tennessee St, Vallejo, CA 94590 Phone: 707-554-3331 Fax: 707-554-3332 | |
La Clinica De La Raza Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 220 Hospital Dr, Vallejo, CA 94589 Phone: 510-535-2958 | |
Medmek Medical Clinic, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 433 Tuolumne St, Suite, Vallejo, CA 94590 Phone: 510-230-3817 |